Vycor Medical

Executive Summary

Vycor Medical, Inc. is a U.S.-based medical technology company focused on neurosurgical and neurotherapeutic solutions through two business units: Vycor Medical, which develops minimally invasive neurosurgical access devices, and NovaVision, offering FDA-cleared computer-based vision rehabilitation therapies for neurological vision loss. The company aims to address unmet needs in neurosurgery and vision restoration, leveraging its proprietary technologies. As a private company with no disclosed funding or revenue, Vycor Medical operates in niche markets with significant clinical demand. Its success hinges on commercial adoption of its products and potential regulatory expansions. The company's current stage is early, with limited public visibility, but its specialized focus could attract strategic partnerships or acquisition interest.

Upcoming Catalysts (preview)

• 2026FDA clearance or CE marking for next-generation neurosurgical access device60% success
• 2026New clinical data or publication supporting NovaVision therapy efficacy50% success
• TBDStrategic partnership or distribution agreement for either business unit40% success